Brief: Rosetta Genomics fortifies intellectual property portfolio with two new patent allowances
03/10/2016 13:00
Oct 3 (Reuters) - Rosetta Genomics Ltd ROSG.O
* Rosetta genomics fortifies intellectual property portfolio
with two new patent allowances for its novel microrna platform
technology
* Allowed korean patent claims method for diagnosing various
cancers, using expression profile of hsa-mir-192, hsa-mir-200c,
hsa-mir-193a
* Received a notice of allowance from kipo for korean patent
application no. 2010-7007495
Source text for Eikon: ID:nBwdB2V7a
Further company coverage: ROSG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics